Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children

OBJECTIVE: Recombinant human growth hormone (rhGH) replacement therapy in children generally requires daily subcutaneous (sc) injections, which may be inconvenient for patients. Jintrolong(®) is a PEGylated rhGH with the purpose of weekly sc injections. The aim of the current study was to examine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Ling, Chen, Zhi-hang, Liu, Dong, Cheng, Yuan-guo, Luo, Xiao-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690642/
https://www.ncbi.nlm.nih.gov/pubmed/26719670
http://dx.doi.org/10.2147/DDDT.S93183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690642/
https://www.ncbi.nlm.nih.gov/pubmed/26719670
http://dx.doi.org/10.2147/DDDT.S93183

Ejemplares similares